Dongbang Medical Co., Ltd (KOSDAQ:240550)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,160.00
-30.00 (-0.42%)
Apr 29, 2026, 3:30 PM KST
-31.94%
Market Cap 149.89B
Revenue (ttm) 113.54B
Net Income (ttm) 11.70B
Shares Out 20.93M
EPS (ttm) 564.00
PE Ratio 12.70
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 132,915
Average Volume 121,902
Open 7,150.00
Previous Close 7,190.00
Day's Range 7,090.00 - 7,500.00
52-Week Range 6,250.00 - 15,130.00
Beta n/a
RSI 55.52
Earnings Date Apr 3, 2026

About Dongbang Medical

Dongbang Medical Co., Ltd produces and sells medical devices, fillers, bio medical devices, and cosmetics devices in South Korea. It offers HA filler, a medical device used for improving facial wrinkles and volume recovery under the ELASTY GRAND, ELASTY DEEP PLUS, ELASTY G PLUS, ELASTY D PLUS, and ELASTY F PLUS names; threads under the ELASTY LINE, ELASTY MESHFILL, ELASTY-V BARB, ELASTY-V UP, ELASTY-V SCREW, and ELASTY-V MONO names; and cannula, needle, and syringe products. The company also provides Hyaluronic acid mask, Beta-Glucan mask, FILL... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1985
Employees 282
Stock Exchange KOSDAQ
Ticker Symbol 240550
Full Company Profile

Financial Performance

In 2025, Dongbang Medical's revenue was 113.54 billion, an increase of 8.01% compared to the previous year's 105.11 billion. Earnings were 11.70 billion, an increase of 301.58%.

Financial Statements

News

There is no news available yet.